NGVT

IngevityNYSE:NGVT Stock Report

Market Cap

US$2.9b

7D

-5.2%

1Y

28.8%

Updated

16 Sep, 2021

Data

Company Financials +
NGVT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance3/6
Financial Health4/6
Dividends0/6

NGVT Overview

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America.

Share Price & News

How has Ingevity's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NGVT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: NGVT's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

-5.2%

NGVT

-0.1%

US Chemicals

-0.6%

US Market


1 Year Return

28.8%

NGVT

23.0%

US Chemicals

33.7%

US Market

Return vs Industry: NGVT exceeded the US Chemicals industry which returned 23% over the past year.

Return vs Market: NGVT underperformed the US Market which returned 33.7% over the past year.


Shareholder returns

NGVTIndustryMarket
7 Day-5.2%-0.1%-0.6%
30 Day-11.0%-1.1%1.4%
90 Day-8.4%2.3%5.4%
1 Year28.8%28.8%25.3%23.0%35.7%33.7%
3 Year-30.1%-30.1%38.2%17.8%61.2%51.2%
5 Year53.0%53.0%96.4%58.6%123.8%99.4%

Long-Term Price Volatility Vs. Market

How volatile is Ingevity's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Ingevity Fundamentals Summary

How do Ingevity's earnings and revenue compare to its market cap?
NGVT fundamental statistics
Market CapUS$2.88b
Earnings (TTM)US$208.90m
Revenue (TTM)US$1.34b

13.8x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NGVT income statement (TTM)
RevenueUS$1.34b
Cost of RevenueUS$803.00m
Gross ProfitUS$533.00m
ExpensesUS$324.10m
EarningsUS$208.90m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)5.13
Gross Margin39.90%
Net Profit Margin15.64%
Debt/Equity Ratio172.3%

How did NGVT perform over the long term?

See historical performance and comparison

Valuation

Is Ingevity undervalued compared to its fair value and its price relative to the market?

43.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NGVT ($72.98) is trading below our estimate of fair value ($127.93)

Significantly Below Fair Value: NGVT is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NGVT is good value based on its PE Ratio (13.8x) compared to the US Chemicals industry average (22.8x).

PE vs Market: NGVT is good value based on its PE Ratio (13.8x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: NGVT is poor value based on its PEG Ratio (1.5x)


Price to Book Ratio

PB vs Industry: NGVT is overvalued based on its PB Ratio (4.2x) compared to the US Chemicals industry average (2.7x).


Future Growth

How is Ingevity forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

9.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NGVT's forecast earnings growth (9.3% per year) is above the savings rate (2%).

Earnings vs Market: NGVT's earnings (9.3% per year) are forecast to grow slower than the US market (14.9% per year).

High Growth Earnings: NGVT's earnings are forecast to grow, but not significantly.

Revenue vs Market: NGVT's revenue (5.7% per year) is forecast to grow slower than the US market (9.7% per year).

High Growth Revenue: NGVT's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NGVT's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Ingevity performed over the past 5 years?

24.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NGVT has high quality earnings.

Growing Profit Margin: NGVT's current net profit margins (15.6%) are higher than last year (13.9%).


Past Earnings Growth Analysis

Earnings Trend: NGVT's earnings have grown significantly by 24.6% per year over the past 5 years.

Accelerating Growth: NGVT's earnings growth over the past year (23.1%) is below its 5-year average (24.6% per year).

Earnings vs Industry: NGVT earnings growth over the past year (23.1%) underperformed the Chemicals industry 38.9%.


Return on Equity

High ROE: Whilst NGVT's Return on Equity (30.34%) is high, this metric is skewed due to their high level of debt.


Financial Health

How is Ingevity's financial position?


Financial Position Analysis

Short Term Liabilities: NGVT's short term assets ($669.6M) exceed its short term liabilities ($232.8M).

Long Term Liabilities: NGVT's short term assets ($669.6M) do not cover its long term liabilities ($1.5B).


Debt to Equity History and Analysis

Debt Level: NGVT's debt to equity ratio (172.3%) is considered high.

Reducing Debt: NGVT's debt to equity ratio has reduced from 356% to 172.3% over the past 5 years.

Debt Coverage: NGVT's debt is well covered by operating cash flow (30.4%).

Interest Coverage: NGVT's interest payments on its debt are well covered by EBIT (7.6x coverage).


Balance Sheet


Dividend

What is Ingevity current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NGVT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NGVT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NGVT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NGVT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NGVT's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

John Fortson (54 yo)

1

Tenure

US$2,831,502

Compensation

Mr. John C. Fortson serves as President, Chief Executive Officer and Director at Ingevity Corporation since September 01, 2020. He served as Interim Chief Financial Officer and Treasurer at Ingevity Corpor...


CEO Compensation Analysis

Compensation vs Market: John's total compensation ($USD2.83M) is below average for companies of similar size in the US market ($USD5.25M).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: NGVT's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

Experienced Board: NGVT's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ingevity Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ingevity Corporation
  • Ticker: NGVT
  • Exchange: NYSE
  • Founded: 2015
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: US$2.884b
  • Shares outstanding: 39.52m
  • Website: https://www.ingevity.com

Number of Employees


Location

  • Ingevity Corporation
  • 4920 O'Hear Avenue
  • Suite 400
  • North Charleston
  • South Carolina
  • 29405
  • United States

Listings


Biography

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company operates t...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/16 22:56
End of Day Share Price2021/09/16 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.